rs1990236
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001372.4(DNAH9):c.13122G>A(p.Met4374Ile) variant causes a missense change. The variant allele was found at a frequency of 0.182 in 1,613,930 control chromosomes in the GnomAD database, including 27,520 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001372.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH9 | NM_001372.4 | c.13122G>A | p.Met4374Ile | missense_variant | 68/69 | ENST00000262442.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH9 | ENST00000262442.9 | c.13122G>A | p.Met4374Ile | missense_variant | 68/69 | 1 | NM_001372.4 | P1 | |
ENST00000580270.1 | n.348-8141C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.173 AC: 26329AN: 151962Hom.: 2390 Cov.: 32
GnomAD3 exomes AF: 0.190 AC: 47605AN: 250890Hom.: 4804 AF XY: 0.185 AC XY: 25101AN XY: 135574
GnomAD4 exome AF: 0.183 AC: 267642AN: 1461850Hom.: 25125 Cov.: 33 AF XY: 0.181 AC XY: 131611AN XY: 727230
GnomAD4 genome AF: 0.173 AC: 26356AN: 152080Hom.: 2395 Cov.: 32 AF XY: 0.173 AC XY: 12895AN XY: 74338
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at